Leaderboards/Cancer Immunotherapy and Biomarkers

Cancer Immunotherapy and Biomarkers

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Hideki Ikeda
Chiba University
2
Zachary Sethna
Memorial Sloan Kettering Cancer Center
3
Jorge Luis Galeano Niño
The University of Texas at El Paso
4
Michelli F. Oliveira
10X Genomics (United States)
5
Ayse Bassez
Vlaams Instituut voor Biotechnologie
6
Laura V. M. Baum
Yale University
7
Lucile Vanhersecke
Institut Bergonié
8
Lawrence P. Andrews
Arc of the United States
9
Rina Kim
The Wistar Institute
10
Shanshan Jiang
Shanghai Jiao Tong University

Papers

1
Immune evasion through mitochondrial transfer in the tumour microenvironment
Nature|2025
248 cit.
2
LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity
Cell|2024
235 cit.
3
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
Nature|2025
232 cit.
4
High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer
Nature Genetics|2025
191 cit.
5
Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest
Cancer Cell|2025
22 cit.
6
1779P Deep learning tertiary lymphoid structures detection on HES/H&E slides and association to survival outcome in sarcoma
Annals of Oncology|2024
1 cit.
7
Publication (2024) [W4401511907]
Unknown Journal|2024
0 cit.
8
Publication in Therapeutic Advances in Medical Oncology (2025) [W4415462109]
Therapeutic Advances in Medical Oncology|2025
0 cit.
9
49P Machine learning refines predictive tertiary lymphoid structures (pTLS) in non-small cell lung cancer (NSCLC) immunotherapy
ESMO Real World Data and Digital Oncology|2025
0 cit.
10
Publication in CA A Cancer Journal for Clinicians (2026) [W7124541709]
CA A Cancer Journal for Clinicians|2026
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Benjamin Izar
Columbia University Irving Medical Center
2
Kellie N. Smith
Bloomberg (United States)
3
Bo Li
Children's Hospital of Philadelphia
4
Martin L. Ferguson
National Cancer Institute
5
Jennifer N. Durham
Sidney Kimmel Comprehensive Cancer Center
6
Bjarne R. Bartlett
State University of New York
7
Hao Wang
University of Electronic Science and Technology of China
8
Adam Abeshouse
Memorial Sloan Kettering Cancer Center
9
Orit Rozenblatt–Rosen
Broad Institute
10
Taiwen Li
Huazhong Agricultural University

Papers

1
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis
Cell|2022
211 cit.
2
Systematic investigation of mitochondrial transfer between cancer cells and T cells at single-cell resolution
Cancer Cell|2023
116 cit.
3
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
Cancer Cell|2023
94 cit.
4
Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity
Nature Cancer|2022
74 cit.
5
Lung tumor–infiltrating T<sub>reg</sub>have divergent transcriptional profiles and function linked to checkpoint blockade response
Science Immunology|2023
74 cit.
6
TIMER3: an enhanced resource for tumor immune analysis
Nucleic Acids Research|2025
63 cit.
7
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens
Nature Genetics|2023
59 cit.
8
Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases
Nature Medicine|2025
50 cit.
9
T cell receptor convergence is an indicator of antigen-specific T cell response in cancer immunotherapies
eLife|2022
45 cit.
10
Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens
Nature Biotechnology|2024
35 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Jedd D. Wolchok
Cornell University
2
Julie R. Brahmer
Johns Hopkins University
3
Antoni Ribas
University of California, Los Angeles
4
X. Shirley Liu
Harbin Medical University
5
Timothy A. Chan
Cleveland Clinic
6
Steven A. Rosenberg
National Cancer Institute
7
James P. Allison
The University of Texas MD Anderson Cancer Center
8
Luis A. Díaz
Memorial Sloan Kettering Cancer Center
9
F. Stephen Hodi
Harvard University
10
Mario Sznol
Yale University

Papers

1
Model-based Analysis of ChIP-Seq (MACS)
Genome biology|2008
19.9k cit.
2
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
New England Journal of Medicine|2010
15.2k cit.
3
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
New England Journal of Medicine|2012
12.7k cit.
4
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
New England Journal of Medicine|2016
10.1k cit.
5
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
New England Journal of Medicine|2015
9.5k cit.
6
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
New England Journal of Medicine|2015
9.4k cit.
7
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
New England Journal of Medicine|2015
8.6k cit.
8
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine|2015
8.1k cit.
9
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
New England Journal of Medicine|2012
8k cit.
10
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Science|2015
7.9k cit.

Reagents for Cancer Immunotherapy and Biomarkers

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Leica BiosystemsEvidence 78

Anti-CD4 and CD8 duo pack Monoclonal Antibody, Unconjugated

Cited in 61 papers
#NCL-CD4/CD8d
View Evidence →
RocheEvidence 75

VENTANA® anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody

Cited in 61 papers
#760-5095 (also 08033706001)
View Evidence →
ProteintechEvidence 75

FcZero-rAb® PE Anti-Human PD-L1/CD274 Rabbit Recombinant Antibody

Cited in 60 papers
#PE-FcA98062$190
View Evidence →

🌟 All-Time

Most validated

ProteintechEvidence 80

CoraLite® Plus 555-conjugated PD-1 VHH

Cited in 65 papers
#CL555-pd1$449
View Evidence →
ProteintechEvidence 80

CoraLite® Plus 647-conjugated PD-1 VHH

Cited in 65 papers
#CL647-pd1$449
View Evidence →
ProteintechEvidence 80

ChromoTek PD-1 VHH, recombinant binding protein for 2x Cys conjugation

Cited in 65 papers
#pd1Cys2$709
View Evidence →